By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bulldog Bio today said that it will distribute Nepa Gene's Nepa21 Electrokinetic Transfection System to labs in the US and Canada.

Portsmouth, NH-based Bulldog Bio will be the sole distributor for those countries. Terms of the distribution pact were not disclosed.

The firm said that Chiba, Japan-based Nepa Gene's system can boost efficiency and reduce toxicity for in vitro transfection experiments without the need for proprietary buffers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.